{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:14:34Z","timestamp":1792512874260,"version":"4.5.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Psoriatic arthritis (PsA) is a phenotypically heterogeneous chronic inflammatory disease associated to type I major histocompatibility complex alleles whose complex pathogenesis is still not completely understood. The psoriatic synovium shares general features of chronic inflammation with rheumatoid arthritis (RA) and other arthritis, such as hyperplasia of the intimal lining layer, sublining influx of inflammatory cells and neoangiogenesis, but recognizing disease-specific histopathologic findings may help in diagnosis and definition of therapeutic targets. Available literature reports conflicting data regarding the extension of lining hyperplasia, that does not allow depiction from RA. Sublining inflammatory cells consist of T and B cells and macrophages, plasma cells, mast cells and follicular dendritic cells, with a higher amount of overall T, mast cell and IL-17 producing CD8+ T lymphocytes and lower proportion of plasma cells when compared to the rheumatoid synovium. The amount of synovium IL17+ CD8+ T cells correlates positively to measures of disease activity. Lymphoid follicles with characteristics of germinal centers have been identified, similar to the ones described in RA. Neoangiogenesis is more prominent in PsA but can also be an outstanding feature in some RA samples, and different molecules involved in the process appear to have different influence in each disease. IL-17 and IL-22 expression in the synovium does not allow depiction between diseases. Among other cytokines and molecules likely implicated in disease physiopathology, only IL-35 is demonstrated to be reduced in PsA when compared to RA.<\/jats:p>","DOI":"10.3389\/fmed.2022.860813","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T06:46:48Z","timestamp":1656658008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Histopathology of Psoriatic Arthritis Synovium\u2014A Narrative Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Catarina","family":"Tenazinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Eurico","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Vieira-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic Arthritis.","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med."},{"key":"B2","first-page":"1051","author":"Michael","year":"0","journal-title":"Rheumatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4419-0298-6_4","article-title":"The enthesis organ concept and its relevance to the spondyloarthropathies.","author":"Benjamin","year":"2009","journal-title":"Molecular Mechanisms of Spondyloarthropathies. Advances in Experimental Medicine and Biology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/rheumatology\/kev330","article-title":"Immunopathology of synovitis: from histology to molecular pathways.","volume":"55","author":"van de Sande","year":"2016","journal-title":"Rheumatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.1780250611","article-title":"Vascular changes in psoriatic synovium. a light and electron microscopic study.","volume":"25","author":"Espinoza","year":"1982","journal-title":"Arthritis Rheum."},{"key":"B6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/01913123.2011.651523","article-title":"Light and electron microscopic features of synovium in patients with psoriatic arthritis.","volume":"36","author":"Zhang","year":"2012","journal-title":"Ultrastructural Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2","article-title":"Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis.","volume":"43","author":"Danning","year":"2000","journal-title":"Arthritis Rheum."},{"key":"B8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/art.1780360705","article-title":"Reduced synovial membrane macrophage numbers, elam-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis.","volume":"36","author":"Veale","year":"1993","journal-title":"Arthritis Rheum."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.656667","article-title":"Synovial immunohistological biomarkers of the classification of undifferentiated arthritis evolving to rheumatoid or psoriatic arthritis.","volume":"8","author":"Cuervo","year":"2021","journal-title":"Front Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/rheumatology\/38.5.431","article-title":"A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis.","volume":"38","author":"Ceponis","year":"1999","journal-title":"Rheumatology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1055\/s-2008-1053510","article-title":"A morphologic contribution to the pathogenesis of psoriatic arthritis.","volume":"118","author":"Rohe","year":"1980","journal-title":"Z Orthop Ihre Grenzgeb."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1898-7","article-title":"Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor\/anti-citrulline antibody-negative rheumatoid arthritis.","volume":"21","author":"Alivernini","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/ar1698","article-title":"Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis.","volume":"7","author":"Kruithof","year":"2005","journal-title":"Arthritis Res Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/ard.2005.050963","article-title":"Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.","volume":"65","author":"van Kuijk","year":"2006","journal-title":"Ann Rheumatic Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/art.20181","article-title":"Antiangiogenic effects of anti-tumor necrosis factor \u03b1 therapy with infliximab in psoriatic arthritis: angiogenesis as a potential therapeutic target in PsA.","volume":"50","author":"Ca\u00f1ete","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B16","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/ard.2006.062042","article-title":"Ectopic lymphoid neogenesis in psoriatic arthritis.","volume":"66","author":"Canete","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/ard.2004.024430","article-title":"p53 Expression in rheumatoid and psoriatic arthritis synovial tissue and association with joint damage.","volume":"64","author":"Salvador","year":"2005","journal-title":"Ann Rheumatic Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/art.33396","article-title":"Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.","volume":"64","author":"Noordenbos","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/ard.45.5.405","article-title":"Immunoglobulin classes in plasma cells of the synovial membrane in chronic inflammatory joint disease.","volume":"45","author":"Revell","year":"1986","journal-title":"Ann Rheum Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.3899\/jrheum.141577","article-title":"Differential Antigen-presenting B Cell phenotypes from synovial microenvironment of patients with rheumatoid and psoriatic arthritis.","volume":"42","author":"Armas-Gonz\u00e1lez","year":"2015","journal-title":"J Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/art.23506","article-title":"Lymphoid follicles in joints: what do they mean?","volume":"58","author":"Edwards","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/art.20012","article-title":"Detection of major histocompatibility complex\/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker.","volume":"50","author":"Baeten","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1002\/art.20476","article-title":"Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patients.","volume":"50","author":"Baeten","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/ar2073","article-title":"Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal\/fibrotic characteristics.","volume":"8","author":"Steenvoorden","year":"2006","journal-title":"Arthritis Res Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/ard.59.12.945","article-title":"Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity.","volume":"59","author":"Baeten","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/1529-0131(199907)42:7<1481::AID-ANR23>3.0.CO;2-E","article-title":"Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis.","volume":"42","author":"Reece","year":"1999","journal-title":"Arthritis Rheum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1046\/j.1365-2133.2000.03544.x","article-title":"Nailfold video capillaroscopy in psoriasis: nailfold capillaroscopy.","volume":"142","author":"Bhushan","year":"2000","journal-title":"Br J Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s002960050028","article-title":"Inflammatory infiltrate and interleukin-8 expression in the synovium of psoriatic arthritis - an immunohistochemical and mRNA analysis.","volume":"17","author":"K\u00f6nig","year":"1997","journal-title":"Rheum Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11926-011-0181-y","article-title":"Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy.","volume":"13","author":"van Kuijk","year":"2011","journal-title":"Curr Rheumatol Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/rheumatology\/kez315","article-title":"Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients.","volume":"59","author":"Kabala","year":"2020","journal-title":"Rheumatology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1136\/annrheumdis-2011-200718","article-title":"Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis.","volume":"71","author":"Krausz","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B32","first-page":"260","article-title":"Angiopoietins, growth factors, and vascular morphology in early arthritis.","volume":"10","author":"Fearon","year":"2018","journal-title":"J. Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ebiom.2019.08.043","article-title":"Dysregulated miR-125a promotes angiogenesis through enhanced glycolysis.","volume":"47","author":"Wade","year":"2019","journal-title":"EBioMedicine."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0426-z","article-title":"Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?","volume":"16","author":"van Baarsen","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128262","article-title":"Gene expression profiling in peripheral blood cells and synovial membranes of patients with psoriatic arthritis.","volume":"10","author":"Dolcino","year":"2015","journal-title":"PLoS One."},{"key":"B36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/art.38995","article-title":"Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis: genomic profiling of psoriatic arthritis.","volume":"67","author":"Belasco","year":"2015","journal-title":"Arthritis Rheum."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/art.38376","article-title":"Interleukin-17+CD8+ T Cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression: IL-17+CD8+ T cell enrichment in the PsA joint.","volume":"66","author":"Menon","year":"2014","journal-title":"Arthritis Rheum."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/ar3781","article-title":"Functional role of IL-22 in psoriatic arthritis.","volume":"14","author":"Mitra","year":"2012","journal-title":"Arthritis Res Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis.","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur J Immunol."},{"key":"B40","first-page":"1544","article-title":"Patterns of cytokine production in psoriatic synovium.","volume":"25","author":"Ritchlin","year":"1998","journal-title":"J Rheumatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1038\/jid.2011.234","article-title":"Inter-Regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis.","volume":"131","author":"Carrier","year":"2011","journal-title":"J Investigat Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1172\/JCI63451","article-title":"Psoriasiform dermatitis is driven by IL-36\u2013mediated DC-keratinocyte crosstalk.","volume":"122","author":"Tortola","year":"2012","journal-title":"J Clin Invest."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15892-7","article-title":"The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function.","volume":"7","author":"Pfaff","year":"2017","journal-title":"Sci Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/rheumatology\/kez358","article-title":"Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis.","volume":"59","author":"Boutet","year":"2020","journal-title":"Rheumatology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/art.39649","article-title":"Interleukin-9 overexpression and Th9 polarization characterize the inflamed gut, the synovial tissue, and the peripheral blood of patients with psoriatic arthritis: IL-9 IN PsA.","volume":"68","author":"Ciccia","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1093\/rheumatology\/kev252","article-title":"Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis.","volume":"54","author":"Ciccia","year":"2015","journal-title":"Rheumatology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cyto.2018.08.001","article-title":"IL-9 receptor: regulatory role on FLS and pannus formation.","volume":"111","author":"Raychaudhuri","year":"2018","journal-title":"Cytokine."},{"key":"B48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/cei.12853","article-title":"Interleukin (IL)-9\/IL-9R axis drives \u03b3\u03b4 T cells activation in psoriatic arthritis patients: IL-9 R expressing \u03b3\u03b4 T cells in psoriatic arthritis.","volume":"186","author":"Guggino","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108253","article-title":"The novel cytokine Metrnl\/IL-41 is elevated in Psoriatic Arthritis synovium and inducible from both entheseal and synovial fibroblasts.","volume":"208","author":"Bridgewood","year":"2019","journal-title":"Clin Immunol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076292","article-title":"Interleukin 15 primes natural killer cells to kill via NKG2D and cPLA2 and this pathway is active in psoriatic arthritis.","volume":"8","author":"Tang","year":"2013","journal-title":"PLoS One."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/ar4038","article-title":"Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.","volume":"14","author":"Lebre","year":"2012","journal-title":"Arthritis Res Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cyto.2015.01.019","article-title":"Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis.","volume":"73","author":"Filkov\u00e1","year":"2015","journal-title":"Cytokine."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189017","article-title":"C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.","volume":"12","author":"Hornum","year":"2017","journal-title":"PLoS One."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1040-z","article-title":"Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis.","volume":"18","author":"Gudmann","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/j.yexcr.2008.02.006","article-title":"Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function.","volume":"314","author":"Abdelmagid","year":"2008","journal-title":"Exp Cell Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1002\/art.27701","article-title":"CD248 and its cytoplasmic domain: a therapeutic target for arthritis: CD248 and its Cytoplasmic Domain in Arthritis.","volume":"62","author":"Maia","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/keg385","article-title":"Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis.","volume":"42","author":"Foell","year":"2003","journal-title":"Rheumatology."},{"key":"B58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/annrheumdis-2014-207201","article-title":"Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors.","volume":"75","author":"Gao","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B59","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment.","volume":"13","author":"Schett","year":"2022","journal-title":"Nat Rev Rheumatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/ard.59.2.135","article-title":"Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis\u2014 cellularity correlates with the degree of enhancement detected by magnetic resonance imaging.","volume":"59","author":"Bollow","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0751-3","article-title":"Enthesitis: much more than focal insertion point inflammation.","volume":"20","author":"Watad","year":"2018","journal-title":"Curr Rheumatol Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/ard.60.4.316","article-title":"Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis.","volume":"60","author":"Laloux","year":"2001","journal-title":"Ann Rheum Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/ard.61.6.534","article-title":"Histological assessment of the early enthesitis lesion in spondyloarthropathy.","volume":"61","author":"McGonagle","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B64","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/rheumatology\/kew369","article-title":"Stratified medicine in rheumatoid arthritis\u2014the MATURA programme.","volume":"56","author":"Barton","year":"2017","journal-title":"Rheumatology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/annrheumdis-2018-214539","article-title":"Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.","volume":"78","author":"Humby","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B66","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/rheumatology\/key069","article-title":"Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis.","volume":"58","author":"Miyagawa","year":"2019","journal-title":"Rheumatology."},{"key":"B67","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/annrheumdis-2014-205417","article-title":"Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis.","volume":"75","author":"Ademowo","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3109\/03009742.2015.1091497","article-title":"Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity.","volume":"45","author":"Bierkarre","year":"2016","journal-title":"Scand J Rheumatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.3899\/jrheum.120201","article-title":"Rituximab treatment for spondyloarthritis. a nationwide series: data from the AIR registry of the French society of rheumatology.","volume":"39","author":"Wendling","year":"2012","journal-title":"J Rheumatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/art.27383","article-title":"Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.","volume":"62","author":"Song","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B71","first-page":"110","article-title":"OP0166 Tocilizumab (TCZ) is not effective for the treatment of ankylosing spondylitis (AS): results of a phase 2, international, multicentre, randomised, double-blind, placebo-controlled trial.","volume":"71","author":"Sieper","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/annrheumdis-2012-201601","article-title":"Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.","volume":"72","author":"Genovese","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/annrheumdis-2016-209831","article-title":"A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate.","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.860813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T06:46:55Z","timestamp":1656658015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.860813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":73,"alternative-id":["10.3389\/fmed.2022.860813"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.860813","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"article-number":"860813"}}